3 Medical Devices Stocks to Sell Now

GIVN, GB, TRNX slump in weekly rankings

   
3 Medical Devices Stocks to Sell Now

The overall ratings of three Medical Devices stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).

Given Imaging (NASDAQ:GIVN) is on the decline this week, earning a D (“sell”) after receiving a C (“hold”) last week. Given Imaging has developed a proprietary wireless imaging system that allows a medical professional to examine the gastrointestinal tract. In Portfolio Grader’s specific subcategory of Earnings Surprise, GIVN also gets an F. The trailing PE Ratio for the stock is 35.10. For a full analysis of GIVN stock, visit Portfolio Grader.

Slipping from a C to a D rating, Greatbatch (NYSE:GB) takes a hit this week. Greatbatch develops and manufactures power sources, feedthroughs, and wet tantalum capacitors used in implantable medical devices. The stock gets F’s in Earnings Growth, Earnings Momentum, and Margin Growth. The stock price has dropped 7.6% over the past month, worse than the 3.9% increase the S&P 500 has seen over the same period of time. For more information, get Portfolio Grader’s complete analysis of GB stock.

Tornier (NASDAQ:TRNX) ratings are on the decline this week as the company earns an F (“strong sell”). Last week, it received a D (“sell”). Tornier designs, outsources the manufacture of and markets orthopedic products. The stock gets F’s in Earnings Momentum and Earnings Revisions. To get an in-depth look at TRNX, get Portfolio Grader’s complete analysis of TRNX stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, http://investorplace.com/2013/05/3-medical-devices-stocks-to-sell-now-givn-gb-trnx-11/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.